Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

HORG trial

Date

30 Sep 2019

Session

Adjuvant treatment duration for high-risk stage II colon cancer

Presenters

Ioannis Souglakos

Authors

I. Souglakos

Author affiliations

  • Medical Oncology Dept, University Hospital of Heraklion (PAGNI), 715 00 - Heraklion/GR
More

Resources

Resources from the same session

TOSCA trial

Presenter: Sara Lonardi

Session: Adjuvant treatment duration for high-risk stage II colon cancer

Resources:

Presentation

Webcast

SCOT trial

Presenter: Timothy Iveson

Session: Adjuvant treatment duration for high-risk stage II colon cancer

Resources:

Presentation

Webcast

Panel discussion

Presenter: Claus-Henning Koehne

Session: Adjuvant treatment duration for high-risk stage II colon cancer

Resources:

Presentation

Webcast

Introduction

Presenter: Alberto Sobrero

Session: Adjuvant treatment duration for high-risk stage II colon cancer

Resources:

Presentation

Webcast

IDEA collaboration for HR stage II

Presenter: Alberto Sobrero

Session: Adjuvant treatment duration for high-risk stage II colon cancer

Resources:

Presentation

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings